DKSH Technology to Acquire Eppendorf’s Operations in Thailand
- DKSH Technology has signed to acquire Eppendorf’s Thailand operations.
- The acquisition includes Eppendorf (Thailand) Co., Ltd. employees.
- This move solidifies DKSH’s standing in Asia’s scientific market.
- Hanno Elbraechter emphasized the strategic benefits of the acquisition.
- Wilson Wang stated excitement over the collaboration with DKSH.
DKSH Expands Presence in Thailand’s Life Sciences Market
DKSH Technology has made a significant move in the life sciences field by signing an agreement to acquire Eppendorf’s direct presence in Thailand. This acquisition is particularly important as it positions DKSH as a leading provider of scientific solutions not just in Asia, but on a broader scale. Eppendorf, known for its comprehensive range of laboratory products, has been a major player in Thailand, especially in sectors involving liquid handling, centrifuges, and general lab equipment.
Integration of Eppendorf Employees and Rights
This transaction will see the full integration of Eppendorf (Thailand) Co., Ltd., including its team of employees, into DKSH’s operations. Importantly, DKSH will also gain exclusive distribution rights for Eppendorf’s products throughout Thailand. Hanno Elbraechter, Head of Business Unit Technology at DKSH, expressed enthusiasm about the acquisition, citing it as part of a broader trend where multinational companies are outsourcing to focus on core capabilities, which in turn benefits DKSH.
Leadership Comments on the Strategic Partnership
Wilson Wang, Senior Vice President of Asia Pacific at Eppendorf Group, also commented on the transaction, highlighting the excitement of partnering with DKSH. He noted that this collaboration will leverage DKSH’s local strengths with Eppendorf’s established reputation and premium offerings. The transaction is set to close in the third quarter of 2025, pending necessary conditions, which suggests a strategic move ahead for both companies.
In summary, DKSH Technology’s acquisition of Eppendorf’s direct presence in Thailand highlights a strategic expansion within the scientific solutions market. This merger not only strengthens DKSH’s capacity in Thailand but promises significant benefits for both companies going forward. As the deal progresses towards closure, the collaboration is anticipated to tap into high-growth sectors like biotech and pharmaceuticals.
